BUZZ-Ebola drug makers: U.S. seeks production plans for ZMapp

Fri Oct 17, 2014 3:19pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Shares of Chimerix Inc down 3.4 pct at $34.21, of Tekmira Pharmaceuticals Corp down 5 pct at $21.68 and of NewLink Genetics Corp down 8.7 pct at $29.10

** U.S. health officials ask 3 advanced biology laboratories to submit plans for producing experimental ebola drug, ZMapp, made by privately held Mapp Pharmaceuticals, government and lab officials said

** Chimerix, Tekmira and NewLink have also developed ebola drugs, which have been used in a few patients